Back to results
US 2003/0199578 A1Published application
Naphthalene amides as potassium channel openers
OwnerSean C. Turner, Neil A. Castle +2inventors
InventorsSean C. Turner, Neil A. Castle, William A. Carroll, Tammie K. White
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds and their ability to act as potassium channel openers.
Claims49
A compound of formula (1):
- 10
- or a pharmaceutically acceptable salt, amide, ester or prodrug thereof wherein,
- X is selected from OH, —O-alkyl, —SH, —S-alkyl, —NH2, —NHR6, —NR6R7;
- R1 and R2 are independently selected from hydrogen, alkyl, alkylcarbonyl, alkoxycarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl, haloalkylcarbonyl, haloalkylsulfonyl, heterocyclecarbonyl, heterocyclesulfonyl, (NR8R9)carbonyl, (NR8R9)sulfonyl;
- R3, R4 is selected from hydrogen, alkyl, aryl, cycloalkyl, haloalkyl, heterocycle;
- R5 is selected from hydrogen, alkenyl, alkenyloxyalkyl, alkoxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, alkyl, alkylcarbonyl, alkylcarbonylalkyl, alkylcarbonyloxyalkyl, alkylsulfonylalkyl, alkynyl, aryl, arylalkoxyalkyl, arylalkoxycarbonyl, arylalkoxycarbonylalkyl, arylalkyl, arylcarbonyl, arylcarbonylalkyl, arylcarbonyloxyalkyl, aryloxyalkyl, aryloxycarbonyl, aryloxycarbonylalkyl, arylalkylthioalkyl, arylsulfonylalkyl, carboxy, carboxyalkyl, cyano, cyanoalkyl, cycloalkyl, cycloalkylalkoxyalkyl, cycloalkylalkyl, cycloalkylcarbonyl, cycloalkyloxyalkyl, cycloalkylalkylthioalkyl, formyl, halogen, haloalkenyl, haloalkyl, haloalkylcarbonyl, haloalkynyl, heterocycle, heterocyclealkoxyalkyl, heterocyclealkyl, heterocyclecarbonyl, heterocycleoxyalkyl, heterocyclealkylthioalkyl, hydroxy, hydroxyalkyl, mercaptoalkyl, nitro, NR10R11, (NR10R11)carbonyl, (NR10R11)carbonylalkyl, (NR10R11)sulfonyl, (NR10R11)sulfonylalkyl;
- R6, R7, R8, R9 R10 and R11 are each independently selected from hydrogen, alkyl, aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, heterocycle, and heterocyclealkyl;
- and
- n is between 0 and 6.
6 more elements
A method of treating disorders in mammals that are ameliorated by potassium channels comprising administering a potassium channel opener.
Dependencies are inferred from the claim text.